USPTO serial 79429309
SCINTIMUN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 4, 2026
- Examiner
- PURATH, ANICKA S
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SCINTIMUN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer, namely, contrast media for use with imaging medical equipment, diagnostic reagents and contrast media for medical use, diagnostic radiopharmaceutical preparations, and radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer | ACTIVE | — |
| 010 | Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes in the nature of drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use being medical imaging apparatus for diagnosing medical conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SCINTIMUN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 4, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 16, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 30, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 30, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 30, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 9, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 9, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 19, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 13, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 7, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |